Alcohol and Substance
Abuse Disorders
Vision - Decrease the clinical impact of alcohol and substance abuse

The program's approach is to organize multidisciplinary, team-based translational research efforts to expedite the process of identifying promising beneficial compounds to conducting human proof-of-principle clinical trials. If successful, this approach could result in translation of contemporary basic science knowledge into enhanced clinical pharmacological treatment protocols for alcohol and substance abuse disorders. Such medications also promise to improve public health and avoid significant social costs. Through research, these new medication-based therapeutic protocols will make a significate impact on alcohol and substance abuse, improving the health and lives of affected service members, their families, and the American public.
Congressional Appropriations
-
$28.075 million
FY10 - FY15 -
$4.0 million
FY16
Funding
Summary
- 1 Award in
FY2014 - Recent Applications Recommended for Funding
Programmatic
Panels
Last updated Monday September 19 2016